Showing results (31-40 of 46) with videos related to
Sort By:
Pageof 5
Retina (Philadelphia, Pa.)|January 4, 2021
FEATURES AND OUTCOMES OF EYES THAT UNDERWENT SURGICAL REPAIR OF RHEGMATOGENOUS RETINAL DETACHMENTS AFTER BEING TREATED FOR ACUTE ENDOPHTHALMITISLibing K Dong, Ryan A Shields, Sam Subramanian, et al.Retina (Philadelphia, Pa.)|November 25, 2010
Posterior vitreous detachment with microplasmin alters the retinal penetration of intravitreal bevacizumab (Avastin) in rabbit eyesDavid T Goldenberg, Frank J Giblin, Mei Cheng, et al.Retina (Philadelphia, Pa.)|May 9, 2008
Repair of primary rhegmatogenous retinal detachment using 25-gauge transconjunctival sutureless vitrectomyMichael M Lai, Alan J Ruby, Ramin Sarrafizadeh, et al.Digital Journal of Ophthalmology : DJO|September 20, 2017
Stalagmite-like preretinal inflammatory deposits in vitrectomized eyes with posterior uveitisYoshihiro Yonekawa, Ashkan M Abbey, Lily van Laere, et al.Journal of Ophthalmic & Vision Research|July 15, 2016
Short-term Efficacy of Intravitreal Dexamethasone Implant in Vitrectomized Eyes with Recalcitrant Diabetic Macular Edema and Prior Anti-VEGF TherapyAnkoor R Shah, Mengqiao Xi, Ashkan M Abbey, et al.American Journal of Ophthalmology|February 10, 2018
Vancomycin-Associated Hemorrhagic Occlusive Retinal Vasculitis: A Clinical-Pathophysiological AnalysisBozho Todorich, Lisa J Faia, Aristomenis Thanos, et al.Retina (Philadelphia, Pa.)|June 17, 2017
DEXAMETHASONE INTRAVITREAL IMPLANT FOR THE TREATMENT OF RECALCITRANT MACULAR EDEMA AFTER RHEGMATOGENOUS RETINAL DETACHMENT REPAIRAristomenis Thanos, Bozho Todorich, Yoshihiro Yonekawa, et al.Retina (Philadelphia, Pa.)|September 1, 2021
LONG-TERM VISUAL OUTCOMES AND THE TIMING OF SURGICAL REPAIR OF FOVEA-SPLITTING RHEGMATOGENOUS RETINAL DETACHMENTSRamon Lee, Ryan A Shields, Michael J Maywood, et al.Retina (Philadelphia, Pa.)|September 24, 2020
PERIPHERAL RETINAL ANGIOGRAPHIC FINDINGS IN MACULAR TELANGIECTASIS TYPE 2Stavros N Moysidis, Nicole Koulisis, Prethy Rao, et al.Retina (Philadelphia, Pa.)|October 30, 2023
LONG-TERM USE OF ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATIONTedi Begaj, Daeun Jeong, Jong G Park, et al.Pageof 5